The Department of Health (DOH) clarified that the four cases of Mycoplasma pneumoniae or “walking pneumonia” in the Philippines are not indicative of a new outbreak.

In a statement released late Wednesday, Dec. 6, DOH said the four cases have already recovered.

“Only four (0.08 percent) of the confirmed ILI (influenza-like illness) cases from January up to Nov. 25, 2023 were due to M. pneumoniae or ‘walking pneumonia’,” it said.

Moreover, DOH said the majority of ILI cases during this period were caused by well-known and commonly detected pathogens, with effective treatments available.

The health department explained that Mycoplasma pneumoniae is recognized as a common pathogen responsible for various infections, including colds and pneumonia.

While it can affect individuals of all age groups, younger children may exhibit cold-like symptoms.

Those with weakened immune systems and individuals residing in closed settings face a higher risk of developing more severe forms of the disease, it added.

Meanwhile, the DOH highlighted that Filipino doctors and medical personnel possess the necessary expertise to treat Mycoplasma pneumoniae, and medications are readily “available” in local hospitals.

The health department has previously detected this pathogen using various methods and affirmed the capability of surveillance systems to identify ILIs and confirm causative agents through laboratory testing.

The DOH reassured the public that the detection of Mycoplasma pneumoniae is neither new nor unusual.

It stressed that preventive measures, including regular handwashing, wearing masks, ensuring adequate ventilation, and staying updated on vaccinations, to mitigate the transmission of Mycoplasma pneumoniae and other respiratory pathogens.

The DOH also urged the public to rely on accurate information and to remain vigilant in adhering to recommended health protocols to safeguard against respiratory infections.